Targeted inhibition of Rev-erb-α/β limits ferroptosis to ameliorate folic acid-induced acute kidney injury.
Lianxia GuoTianpeng ZhangFei WangXun ChenHaiman XuCui ZhouMin ChenFangjun YuShuai WangDeguang YangBaojian WuPublished in: British journal of pharmacology (2020)
Targeted inhibition of Rev-erb-α/β limits ferroptosis to ameliorate folic acid-induced AKI in mice. The findings may have implications for improved understanding of circadian clock-controlled ferroptosis and for formulating new strategies to treat AKI.